Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study.
Mazzotta V, Lepri AC, Matusali G, Cimini E, Piselli P, Aguglia C, Lanini S, Colavita F, Notari S, Oliva A, Meschi S, Casetti R, Mondillo V, Vergori A, Bettini A, Grassi G, Pinnetti C, Lapa D, Tartaglia E, Gallì P, Mondi A, Montagnari G, Gagliardini R, Nicastri E, Lichtner M, Sarmati L, Tamburrini E, Mastroianni C, Stingone C, Siddu A, Barca A, Fontana C, Agrati C, Girardi E, Vaia F, Maggi F, Antinori A; Mpox Vaccine Lazio Study Group. Mazzotta V, et al. EClinicalMedicine. 2024 Jan 12;68:102420. doi: 10.1016/j.eclinm.2023.102420. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38292040 Free PMC article.
Pharmacokinetics of tecovirimat in subjects with Mpox.
Tempestilli M, Mondi A, D'Avolio A, Forini O, Pinnetti C, Mazzotta V, Gagliardini R, Beccacece A, De Nicolò A, Faccendini P, Cimini E, Maggi F, Girardi E, Nicastri E, Boffito M, Vaia F, Antinori A. Tempestilli M, et al. Among authors: faccendini p. Int J Antimicrob Agents. 2024 Feb;63(2):107068. doi: 10.1016/j.ijantimicag.2023.107068. Epub 2023 Dec 22. Int J Antimicrob Agents. 2024. PMID: 38141836 Free article.
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
Mazzotta V, Cozzi-Lepri A, Lanini S, Mondi A, Carletti F, Tavelli A, Gagliardini R, Vita S, Pinnetti C, Aguglia C, Colavita F, Faccendini P, Matusali G, Faraglia F, Beccacece A, Paulicelli J, Girardi E, Nicastri E, Vaia F, Maggi F, Antinori A. Mazzotta V, et al. Among authors: faccendini p. J Med Virol. 2023 Jun;95(6):e28868. doi: 10.1002/jmv.28868. J Med Virol. 2023. PMID: 37306318 Clinical Trial.
Tecovirimat concentrations and viral suppression in seminal fluid from patients with mpox.
Tempestilli M, Mondi A, Matusali G, Mariotti D, Pinnetti C, Beccacece A, Cimini E, Mazzotta V, Carletti F, Faccendini P, Maggi F, Girardi E, Nicastri E, Vaia F, Antinori A. Tempestilli M, et al. Among authors: faccendini p. Lancet Infect Dis. 2023 May;23(5):531-532. doi: 10.1016/S1473-3099(23)00214-1. Epub 2023 Mar 30. Lancet Infect Dis. 2023. PMID: 37004668 No abstract available.
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital.
Mondi A, Gagliardini R, Mazzotta V, Vita S, Carletti F, Pinnetti C, Giancola ML, Specchiarello E, Lanini S, Faraglia F, Minosse C, Paulicelli J, Mariano A, Rozera G, Fontana C, Faccendini P, Maggi F, Girardi E, Vaia F, Nicastri E, Antinori A. Mondi A, et al. Among authors: faccendini p. J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.11.001. Epub 2022 Nov 5. J Infect. 2023. PMID: 36347428 Free PMC article. No abstract available.